Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.87%1.79B | -3.40%1.79B | 36.72%2.31B | 16.63%7.38B | 16.83%2.15B | 26.74%1.84B | 30.45%1.86B | -0.53%1.69B | -45.47%6.33B | -31.97%1.84B |
| Operating revenue | -2.87%1.79B | -3.40%1.79B | 48.18%2.28B | 16.63%7.38B | 16.83%2.15B | 26.74%1.84B | 30.45%1.86B | -4.82%1.54B | -45.47%6.33B | -31.97%1.84B |
| Cost of revenue | 3.28%1.13B | -2.69%1.01B | 44.02%1.38B | 16.53%4.07B | 13.69%1.12B | 37.81%1.1B | 36.30%1.04B | -6.52%961M | -58.87%3.49B | -51.14%986M |
| Gross profit | -11.91%658M | -4.29%780M | 27.12%928M | 16.76%3.32B | 20.47%1.02B | 13.35%747M | 23.67%815M | 8.63%730M | -9.06%2.84B | 24.82%850M |
| Operating expense | -13.71%107M | 12.94%96M | 49.46%139M | 0.72%419M | -22.00%117M | 42.53%124M | -8.60%85M | 8.14%93M | -21.21%416M | -36.97%150M |
| Selling and administrative expenses | 5.00%126M | -13.39%97M | 24.07%134M | 5.21%444M | -26.76%104M | 15.38%120M | 33.33%112M | 17.39%108M | 5.76%422M | 12.70%142M |
| -General and administrative expense | 5.00%126M | -13.39%97M | 24.07%134M | 5.21%444M | -26.76%104M | 15.38%120M | 33.33%112M | 17.39%108M | 5.76%422M | 12.70%142M |
| Other operating expenses | -575.00%-19M | 96.30%-1M | 133.33%5M | -316.67%-25M | 62.50%13M | 123.53%4M | -400.00%-27M | -150.00%-15M | -104.65%-6M | -92.86%8M |
| Operating profit | -11.56%551M | -6.30%684M | 23.86%789M | 19.51%2.9B | 29.57%907M | 8.92%623M | 28.98%730M | 8.70%637M | -6.59%2.42B | 58.01%700M |
| Net non-operating interest income (expenses) | -2.68%-153M | -4.14%-151M | -45.10%-148M | -18.57%-549M | -34.21%-153M | -26.27%-149M | -23.93%-145M | 10.53%-102M | -0.22%-463M | 2.56%-114M |
| Non-operating interest income | -42.86%4M | -88.89%1M | -89.66%3M | 557.14%46M | -66.67%1M | 600.00%7M | 800.00%9M | 1,350.00%29M | --7M | --3M |
| Non-operating interest expense | 0.64%157M | -1.30%152M | 15.27%151M | 26.60%595M | 31.62%154M | 31.09%156M | 30.51%154M | 12.93%131M | 1.73%470M | 0.00%117M |
| Other net income (expenses) | 66.67%-2M | -375.44%-628M | -104.37%-10M | -7,750.00%-612M | -300.00%-6M | -79.01%228M | 5,625.00%229M | |||
| Gain on sale of security | ---- | ---- | 66.67%-2M | -300.00%-12M | -400.00%-10M | ---- | -50.00%4M | -300.00%-6M | 87.50%-3M | -150.00%-2M |
| Special income (charges) | --0 | --0 | ---- | -366.67%-616M | --0 | --0 | ---616M | ---- | -79.19%231M | --231M |
| -Less:Restructuring and mergern&acquisition | --0 | --0 | ---- | --616M | --0 | --0 | --616M | ---- | --0 | --0 |
| -Less:Write off | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---231M | ---- |
| Income before tax | -16.03%398M | 2,074.07%533M | 20.79%639M | -21.43%1.72B | -8.71%744M | 7.24%474M | -105.91%-27M | 11.37%529M | -32.00%2.19B | 146.97%815M |
| Income tax | 25.84%112M | 122.92%116M | 50.55%137M | -137.29%-154M | 47.01%172M | -7.29%89M | -638.30%-506M | -14.15%91M | 66.53%413M | 34.48%117M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -25.71%286M | -12.94%417M | 14.61%502M | 5.52%1.87B | -18.05%572M | 11.27%385M | 31.96%479M | 18.70%438M | -40.22%1.78B | 187.24%698M |
| Net income continuous operations | -25.71%286M | -12.94%417M | 14.61%502M | 5.52%1.87B | -18.05%572M | 11.27%385M | 31.96%479M | 18.70%438M | -40.22%1.78B | 187.24%698M |
| Noncontrolling interests | 0 | 0 | 10M | 0 | 2M | 8M | 0 | 0 | ||
| Net income attributable to the company | -25.33%286M | -11.46%417M | 14.61%502M | 4.95%1.86B | -18.05%572M | 10.69%383M | 29.75%471M | 18.70%438M | -40.22%1.78B | 187.24%698M |
| Preferred stock dividends | 11.72%143M | 15.63%37M | 23.33%37M | -0.78%128M | 10.34%32M | |||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -25.33%286M | -11.46%417M | 14.61%502M | 4.43%1.72B | -35.59%429M | 21.20%383M | 29.75%471M | 18.70%438M | -42.01%1.65B | 211.21%666M |
| Diluted earnings per share | -28.33%0.43 | -13.33%0.65 | 8.11%0.8 | 0.00%3 | -23.97%0.92 | 3.45%0.6 | 25.00%0.75 | 21.31%0.74 | -41.63%3 | 210.26%1.21 |
| Basic earnings per share | -28.33%0.43 | -13.33%0.65 | 9.59%0.8 | 0.33%3 | -23.97%0.92 | 5.26%0.6 | 25.00%0.75 | 19.67%0.73 | -41.60%2.99 | 210.26%1.21 |
| Dividend per share | 2.90%0.71 | 2.90%0.71 | 3.37%0.69 | 3.11%2.7375 | 3.37%0.69 | 3.37%0.69 | 3.37%0.69 | 2.30%0.6675 | 4.12%2.655 | 2.30%0.6675 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.